Substitute House Bill No. 6436, now Public Act No. 25-132, introduces several revisions to the health insurance statutes, effective from October 1, 2025. A key change is the establishment of a health benefit review program within the Insurance Department, which will evaluate mandated health benefits as requested by the General Assembly's insurance committee. This program will be funded by the Insurance Fund, and the commissioner will have the authority to make assessments for its operational costs. The bill also modifies the process for engaging experts for the review and evaluation of mandated health benefits, allowing the commissioner to engage various independent experts as deemed necessary, rather than contracting exclusively with The University of Connecticut Center for Public Health and Health Policy.

Additionally, the bill revises reporting requirements for pharmacy benefits managers, extending the deadline for annual reports from February 1, 2025, to March 1, 2026, and subsequently each year. These reports must include detailed information about rebates from pharmaceutical manufacturers related to outpatient prescription drugs. The commissioner is tasked with creating a standardized reporting form to ease the administrative burden and ensuring that submitted information remains confidential under the Freedom of Information Act. The bill also allows the commissioner to impose penalties for non-compliance and grants the commissioner the discretion to adopt regulations to implement these provisions, rather than mandating it.

Statutes affected:
Raised Bill:
INS Joint Favorable:
File No. 53:
Public Act No. 25-132: